MedTrace Logo

Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics

NCT01873872 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-03-28

No results posted yet for this study

Summary

We have designed this study to measure the effect of normal flora supplementation, using available probiotics, on the incidence of Clostridium difficile-associated diarrhea

in a population of general inpatients who are receiving antibiotics.

Conditions

  • Development of Clostridium Difficile Associated Diarrhea

Interventions

DIETARY_SUPPLEMENT

Theralac probiotic

DIETARY_SUPPLEMENT

Culturelle probiotic

OTHER

placebo

Sponsors & Collaborators

  • Master Supplements, Inc

    collaborator OTHER

  • St. Vincent's East, Birmingham, Alabama

    lead OTHER

Principal Investigators

  • Leanne Phillips, Pharm.D · St. Vincent's East

  • Walter Ross, MD · St. Vincent's East

  • Mark Middlebrooks, MD · St. Vincent's East

  • Lee Wimberly, MD · St. Vincent's East

  • Linda Adams, RPh · St. Vincent's East

  • Carrie Castleberry, RN · St. Vincent's East

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01873872 on ClinicalTrials.gov